12/20
08:55 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $86.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $86.00 price target on the stock.
12/20
08:55 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $86.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $86.00 price target on the stock.
12/20
08:48 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
12/20
08:48 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
12/10
08:00 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $94.00 price target on the stock.
Medium
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $94.00 price target on the stock.
12/10
07:38 am
crsp
Rating for CRSP
Medium
Report
Rating for CRSP
11/6
11:19 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $53.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $53.00 price target on the stock.
11/6
11:19 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $53.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $53.00 price target on the stock.
11/6
11:17 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
11/6
11:17 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
11/6
09:18 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
11/6
09:18 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
11/6
08:07 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $84.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $84.00 price target on the stock.
11/6
05:30 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
11/6
05:30 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
10/4
11:33 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP
10/4
11:33 am
crsp
Rating for CRSP
Low
Report
Rating for CRSP